Loading company…
Vivos develops treatments and devices for sleep-related breathing disorders, including obstructive sleep apnea.
Founded in 2013 by Dave Singh and R. Kirk Huntsman, Vivos develops medical devices and treatments for sleep-related breathing disorders. Its Vivos Method uses oral appliance technology to address dentofacial abnormalities and obstructive sleep apnea in adults, with other therapies as needed. The company is based in Littleton, US, and trades on NASDAQ as VVOS. In June 2024, Seneca Partners invested USD 7.5 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in